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I enjoyed the article by Ramezani et al., ‘‘Detection of
hepatitis G virus envelope protein E2 antibody in blood
donors,’’ published in a recent issue of the International
Journal of Infectious Diseases,1 and would like to make some
comments on this article.
Firstly, the authors evaluated hepatitis G virus (HGV)
antibody and ribonucleic acid (RNA) among 478 blood donors
in Tabriz City, but then went on to reflect their results onto
the whole population of Iranian blood donors. Iran is a
country with a population of more than 70 000 000, and a
survey in the northwest of the country, on 478 samples,
cannot be representative of the HGV status for all Iranian
blood donors. The pattern of prevalence of hepatitis G may
well be different in the various other regions of Iran. For
example, Gharebaghian et al. showed the hepatitis G pre-
valence in Tehran, the capital of Iran, to be 4.2% among 330
blood donors,2 a higher prevalence value than that deter-
mined by Ramezani et al. The current prevalence of virus in
other parts of the country remains to be elucidated, and then
a meta-analysis will determine the countrywide pattern.
Secondly, in liver function tests, the mean levels of ALTand
ASTwere cited for both groups — thosewith positive results forHGV and those with negative results for HGV; however, no
reference rangeswere given, whichmakes the description and
interpretation of the results somehow confusing.
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Dear Dr Cameron
Thank you for sending me the letter from H. Mansouri-
torghabeh concerning my article entitled ‘‘Detection of
hepatitis G virus envelope protein E2 antibody in blood
donors,’’ published in the International Journal of Infectious
Diseases.In reply to the first point made, because Tabriz City is not
well known to scholars around the world, we used ‘Iran’ in
the ‘Aims’ section to give readers an immediate understand-
ing of the place of study; however in the ‘Patients and
methods’ section it was explained that the study took place
in Tabriz City. This policy is common inmany papers published
in international journals.1—5 Also, we did not reflect our
results onto all Iranian blood donors. As mentioned in the
‘Discussion’ section, ‘‘We have shown a low frequency of
